Internalization and fate of silica nanoparticles in C2C12 skeletal muscle cells: Evidence of a beneficial effect on myoblast fusion

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 1479-1492

  Poussard, Sylvie ^a,b   Decossas, Marion ^a,b   Le Bihan, Olivier ^a,b   Mornet, Stéphane ^a   Naudin, Grégoire ^a,b   Lambert, Olivier ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CNRS   (France)

Author keywords

Apoptosis; Cell encapsulation; Muscle; Nanoparticle; Silica; Transmission electron microscopy

Indexed keywords

CLATHRIN; SILICA NANOPARTICLE; NANOPARTICLE; SILICON DIOXIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL FATE; CELL FUSION; CELL MIGRATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOCYTOSIS; INTERNALIZATION; LYSOSOME; MOUSE; MYOBLAST; MYOTUBE; NONHUMAN; PINOCYTOSIS; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; CELL LINE; CHEMISTRY; DRUG EFFECTS; HUMAN; METABOLISM; SKELETAL MUSCLE CELL;

CELL DIFFERENTIATION; CELL LINE; HUMANS; MUSCLE FIBERS, SKELETAL; MYOBLASTS; NANOPARTICLES; SILICON DIOXIDE;

EID: 84923260974     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S74158     Document Type: Article

References (49)

1. Biju V. Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy. Chem Soc Rev. 2014;43(3):744–764.
2. Nel A, Xia T, Mädler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311(5761):622–627.
3. Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline volving from studies of ultrafine particles. Environ Health Perspect. 2005;113(7):823- 839.
4. Napierska D, Thomassen LCJ, Lison D, Martens JA, Hoet PH. The nanosilica hazard: another variable entity. Part Fibre Toxicol. 2010; 7(1):39.
5. Mu Q, Hondow NS, Krzemiński L, Brown AP, Jeuken LJC, Routledge MN. Mechanism of cellular uptake of genotoxic silica nanoparticles. Part Fibre Toxicol. 2012;9(1):29.
6. Bauer AT, Strozyk EA, Gorzelanny C, et al. Cytotoxicity of silica nanoparticles through exocytosis of von Willebrand factor and necrotic cell death in primary human endothelial cells. Biomaterials. 2011;32(33): 8385–8393.
7. Uboldi C, Giudetti G, Broggi F, Gilliland D, Ponti J, Rossi F. Amorphous silica nanoparticles do not induce cytotoxicity, cell transformation or genotoxicity in Balb/3T3 mouse fibroblasts. Mutat Res. 2012;745(1–2): 11–20.
8. Stern ST, Adiseshaiah PP, Crist RM. Autophagy and lysosomal dysfunction.
9. as emerging mechanisms of nanomaterial toxicity. Part Fibre Toxicol. 2012;9(1):20.
10. McCarthy J, Inkielewicz-Stępniak I, Corbalan JJ, Radomski MW. Mechanisms of toxicity of amorphous silica nanoparticles on human lung submucosal cells in vitro: protective effects of fisetin. Chem Res Toxicol. 2012;25(10):2227–2235.
11. Corbalan JJ, Medina C, Jacoby A, Malinski T, Radomski MW. Amorphous silica nanoparticles trigger nitric oxide/peroxynitrite imbalance in human endothelial cells: inflammatory and cytotoxic effects. Int J Nanomedicine. 2011;6:2821–2835.
12. Slowing II, Vivero-Escoto JL, Wu C-W, Lin VS-Y. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev. 2008;60(11):1278–1288.
13. Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VS-Y. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small. 2010;6(18):1952–1967.
14. Bharali DJ, Klejbor I, Stachowiak EK, et al. Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. Proc Natl Acad Sci U S A. 2005;102(32):11539–11544.
15. Wang Y, Xu C, Ow H. Commercial nanoparticles for stem cell labeling and tracking. Theranostics. 2013;3(8):544–560.
16. Zielinska M, Sawosz E, Grodzik M, et al. Effect of heparan sulfate and gold nanoparticles on muscle development during embryogenesis. Int J Nanomedicine. 2011;6:3163–3172.
17. Davis ME, Chen ZG, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov. 2008;7(9): 771–782.
18. Benezra M, Penate-Medina O, Zanzonico PB, et al. Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J Clin Invest. 2011;121(7):2768–2780.
19. Pauly M, Daussin F, Burelle Y, et al. AMPK activation stimulates autophagy and ameliorates muscular dystrophy in the mdx mouse diaphragm. Am J Pathol. 2012;181(2):583–592.
20. Bibee KP, Cheng Y-J, Ching JK, et al. Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function. FASEB J. 2014;28(5):2047–2061.
21. Böcking D, Wiltschka O, Niinimäki J, et al. Mesoporous silica nanoparticle-based substrates for cell directed delivery of Notch signaling modulators to control myoblast differentiation. Nanoscale. 2014; 6(3):1490–1498.
22. Rivière C, Lecoeur C, Wilhelm C, et al. The MRI assessment of intraurethrally-delivered muscle precursor cells using anionic magnetic nanoparticles. Biomaterials. 2009;30(36):6920–6928.
23. Rochlin K, Yu S, Roy S, Baylies MK. Myoblast fusion: when it takes more to make one. Dev Biol. 2010;341(1):66–83.
24. Abmayr SM, Pavlath GK. Myoblast fusion: lessons from flies and mice. Development. 2012;139(4):641–656.
25. Tapscott SJ. The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development. 2005;132(12): 2685–2695.
26. Hochreiter-Hufford AE, Lee CS, Kinchen JM, et al. Phosphatidylserine receptor BAI1 and apoptotic cells as new promoters of myoblast fusion. Nature. 2013;497(7448):263–267.
27. Vranic S, Boggetto N, Contremoulins V, et al. Deciphering the mechanisms of cellular uptake of engineered nanoparticles by accurate evaluation of internalization using imaging flow cytometry. Part Fibre Toxicol. 2013;10(1):2.
28. Van Blaaderen A, Vrij A. Synthesis and characterization of colloidal dispersions of fluorescent, monodisperse silica spheres. Langmuir. 1992;8(12):2921–2931.
29. Pajcini KV, Pomerantz JH, Alkan O, Doyonnas R, Blau HM. Myoblasts and macrophages share molecular components that contribute to cell-cell fusion. J Cell Biol. 2008;180(5):1005–1019.
30. Shapero K, Fenaroli F, Lynch I, Cottell DC, Salvati A, Dawson KA. Time and space resolved uptake study of silica nanoparticles by human cells. Mol Biosyst. 2011;7(2):371–378.
31. Lu J, Liong M, Sherman S, et al. Mesoporous Silica Nanoparticles for Cancer Therapy: Energy-Dependent Cellular Uptake and Delivery of Paclitaxel to Cancer Cells. NanoBiotechnology. 2007;3(2): 89–95.
32. Xing X, He X, Peng J, Wang K, Tan W. Uptake of silica-coated nanoparticles by HeLa cells. J Nanosci Nanotechnol. 2005;5(10):1688–1693.
33. Geiser M, Rothen-Rutishauser B, Kapp N, et al. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect. 2005;113(11):1555–1560.
34. Rothen-Rutishauser BM, Schürch S, Haenni B, Kapp N, Gehr P. Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ Sci Technol. 2006;40(14):4353–4359.
35. Le Bihan O, Bonnafous P, Marak L, et al. Cryo-electron tomography of nanoparticle transmigration into liposome. J Struct Biol. 2009;168(3): 419–425.
36. Zhao Y, Sun X, Zhang G, Trewyn BG, Slowing II, Lin VS-Y. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects. ACS Nano. 2011;5(2): 1366–1375.
37. Geiser M, Kreyling WG. Deposition and biokinetics of inhaled nanoparticles. Part Fibre Toxicol. 2010;7(1):2.
38. Rancan F, Gao Q, Graf C, et al. Skin penetration and cellular uptake of amorphous silica nanoparticles with variable size, surface functionalization, and colloidal stability. ACS Nano. 2012;6(8):6829–6842.
39. Bergin IL, Witzmann FA. Nanoparticle toxicity by the gastrointestinal route evidence and knowledge gaps. Int J Biomed Nanosci Nanotechnol. 2013;3(1–2).
40. Jokerst JV, Thangaraj M, Kempen PJ, Sinclair R, Gambhir SS. Photoacoustic imaging of mesenchymal stem cells in living mice via silica-coated gold nanorods. CS Nano. 2012;6(7):5920–5930.
41. Rose S, Prevoteau A, Elzière P, Hourdet D, Marcellan A, Leibler L. Nanoparticle solutions as adhesives for gels and biological tissues. Nature. 2014;505(7483):382–385.
42. Besic Gyenge E, Darphin X, Wirth A, et al. Uptake and fate of surface modified silica nanoparticles in head and neck squamous cell carcinoma. J Nanobiotechnology. 2011;9(1):32.
43. Hunt LC, Upadhyay A, Jazayeri JA, Tudor EM, White JD. Caspase-3, myogenic transcription factors and cell cycle inhibitors are regulated by leukemia inhibitory factor to mediate inhibition of myogenic differentiation. Skelet Muscle. 2011;1(1):17.
44. Lee S, Yun H-S, Kim S-H. The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis. Biomaterials. 2011;32(35):9434–9443.
45. Lu X, Qian J, Zhou H, et al. In vitro cytotoxicity and induction of apoptosis by silica nanoparticles in human HepG2 hepatoma cells. Int J Nanomedicine. 2011;6:1889–1901.
46. Duan J, Yu Y, Li Y, Yu Y, Sun Z. Cardiovascular toxicity evaluation of silica nanoparticles in endothelial cells and zebrafish model. Biomaterials. 2013;34(23):5853–5862.
47. Singh K, Dilworth FJ. Differential modulation of cell cycle progression distinguishes members of the myogenic regulatory factor family of transcription factors. FEBS J. 2013;280(17):3991–4003.
48. Krampera M, Pizzolo G, Aprili G, Franchini M. Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone. 2006;39(4):678–683.
49. Meregalli M, Farini A, Belicchi M, et al. Perspectives of stem cell therapy in Duchenne muscular dystrophy. FEBS J. 2013;280(17):4251–4262.